230 related articles for article (PubMed ID: 23977965)
1. High levels of IgG3 anti ICB2-5 in Plasmodium vivax-infected individuals who did not develop symptoms.
Versiani FG; Almeida ME; Melo GC; Versiani FO; Orlandi PP; Mariúba LA; Soares LA; Souza LP; da Silva Balieiro AA; Monteiro WM; Costa FT; del Portillo HA; Lacerda MV; Nogueira PA
Malar J; 2013 Aug; 12():294. PubMed ID: 23977965
[TBL] [Abstract][Full Text] [Related]
2. Malaria transmission and individual variability of the naturally acquired IgG antibody against the Plasmodium vivax blood-stage antigen in an endemic area in Brazil.
Costa EMF; Amador ECC; Silva ES; Alvarenga CO; Pereira PE; Póvoa MM; Cunha MG
Acta Trop; 2020 Sep; 209():105537. PubMed ID: 32454033
[TBL] [Abstract][Full Text] [Related]
3. Naturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia.
Wang Q; Zhao Z; Zhang X; Li X; Zhu M; Li P; Yang Z; Wang Y; Yan G; Shang H; Cao Y; Fan Q; Cui L
PLoS One; 2016; 11(3):e0151900. PubMed ID: 26999435
[TBL] [Abstract][Full Text] [Related]
4. Antibody response to the N and C-terminal regions of the Plasmodium vivax Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil.
Soares IS; Oliveira SG; Souza JM; Rodrigues MM
Acta Trop; 1999 Jan; 72(1):13-24. PubMed ID: 9924957
[TBL] [Abstract][Full Text] [Related]
5. IgG subclasses pattern and high-avidity antibody to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in an unstable hypoendemic region in Iran.
Mehrizi AA; Zakeri S; Salmanian AH; Sanati MH; Djadid ND
Acta Trop; 2009 Oct; 112(1):1-7. PubMed ID: 19481997
[TBL] [Abstract][Full Text] [Related]
6. Naturally-acquired humoral immune responses against the N- and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay.
Fernandez-Becerra C; Sanz S; Brucet M; Stanisic DI; Alves FP; Camargo EP; Alonso PL; Mueller I; del Portillo HA
Malar J; 2010 Jan; 9():29. PubMed ID: 20092651
[TBL] [Abstract][Full Text] [Related]
7. A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1.
Nogueira PA; Alves FP; Fernandez-Becerra C; Pein O; Santos NR; Pereira da Silva LH; Camargo EP; del Portillo HA
Infect Immun; 2006 May; 74(5):2726-33. PubMed ID: 16622209
[TBL] [Abstract][Full Text] [Related]
8. Naturally acquired antibodies to Plasmodium vivax blood-stage vaccine candidates (PvMSP-1₁₉ and PvMSP-3α₃₅₉₋₇₉₈ and their relationship with hematological features in malaria patients from the Brazilian Amazon.
Mourão LC; Morais CG; Bueno LL; Jimenez MC; Soares IS; Fontes CJ; Guimarães Lacerda MV; Xavier MS; Barnwell JW; Galinski MR; Braga EM
Microbes Infect; 2012 Aug; 14(9):730-9. PubMed ID: 22445906
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal study of naturally acquired humoral immune responses against the merozoite surface protein 1 of Plasmodium vivax in patients from Rondonia, Brazil.
Mertens F; Levitus G; Camargo LM; Ferreira MU; Dutra AP; Del Portillo HA
Am J Trop Med Hyg; 1993 Sep; 49(3):383-92. PubMed ID: 8372960
[TBL] [Abstract][Full Text] [Related]
10. Host genetic polymorphisms and serological response against malaria in a selected population in Sri Lanka.
Dewasurendra RL; Jeffreys A; Gunawardena SA; Chandrasekharan NV; Rockett K; Kwiatkowski D; Karunaweera ND
Malar J; 2018 Dec; 17(1):473. PubMed ID: 30558622
[TBL] [Abstract][Full Text] [Related]
11. IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria.
Pitabut N; Panichakorn J; Mahakunkijcharoen Y; Hirunpetcharat C; Looareesuwan S; Khusmith S
Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):1-7. PubMed ID: 17539238
[TBL] [Abstract][Full Text] [Related]
12. Identification and serological responses to a novel
Marzano-Miranda A; Pereira Cardoso-Oliveira G; Carla de Oliveira I; Carvalho Mourão L; Reis Cussat L; Gomes Fraga V; Delfin Chávez Olórtegui C; Jesus Fernandes Fontes C; Castanheira Bartholomeu D; Braga EM
PeerJ; 2024; 12():e17632. PubMed ID: 38948214
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of naturally acquired immune responses against novel pre-erythrocytic Plasmodium vivax proteins in a low endemic malaria population located in the Peruvian Amazon Basin.
Ventocilla JA; Tapia LL; Ponce R; Franco A; Leelawong M; Aguiar JC; Baldeviano GC; Wilder BK
Malar J; 2024 May; 23(1):163. PubMed ID: 38783317
[TBL] [Abstract][Full Text] [Related]
14. Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India.
Kale S; Yadav CP; Rao PN; Shalini S; Eapen A; Srivasatava HC; Sharma SK; Pande V; Carlton JM; Singh OP; Mallick PK
Malar J; 2019 Dec; 18(1):425. PubMed ID: 31842894
[TBL] [Abstract][Full Text] [Related]
15. Analysis of naturally acquired antibody responses to the 19-kd C-terminal region of merozoite surface protein-1 of Plasmodium vivax from individuals in Sanliurfa, Turkey.
Zeyrek FY; Babaoglu A; Demirel S; Erdogan DD; Ak M; Korkmaz M; Coban C
Am J Trop Med Hyg; 2008 May; 78(5):729-32. PubMed ID: 18458304
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses.
Min HMK; Changrob S; Soe PT; Han JH; Muh F; Lee SK; Chootong P; Han ET
Malar J; 2017 Aug; 16(1):354. PubMed ID: 28854974
[TBL] [Abstract][Full Text] [Related]
17. Immunogenetic markers associated with a naturally acquired humoral immune response against an N-terminal antigen of Plasmodium vivax merozoite surface protein 1 (PvMSP-1).
Cassiano GC; Furini AA; Capobianco MP; Storti-Melo LM; Almeida ME; Barbosa DR; Póvoa MM; Nogueira PA; Machado RL
Malar J; 2016 Jun; 15():306. PubMed ID: 27255376
[TBL] [Abstract][Full Text] [Related]
18. IgG antibodies to synthetic GPI are biomarkers of immune-status to both Plasmodium falciparum and Plasmodium vivax malaria in young children.
França CT; Li Wai Suen CSN; Carmagnac A; Lin E; Kiniboro B; Siba P; Schofield L; Mueller I
Malar J; 2017 Sep; 16(1):386. PubMed ID: 28946883
[TBL] [Abstract][Full Text] [Related]
19. Serologically defined variations in malaria endemicity in Pará state, Brazil.
Cunha MG; Silva ES; Sepúlveda N; Costa SP; Saboia TC; Guerreiro JF; Póvoa MM; Corran PH; Riley E; Drakeley CJ
PLoS One; 2014; 9(11):e113357. PubMed ID: 25419900
[TBL] [Abstract][Full Text] [Related]
20. Assessment of IgG3 as a serological exposure marker for
Tayipto Y; Rosado J; Gamboa D; White MT; Kiniboro B; Healer J; Opi DH; Beeson JG; Takashima E; Tsuboi T; Harbers M; Robinson L; Mueller I; Longley RJ
Front Cell Infect Microbiol; 2022; 12():950909. PubMed ID: 36017364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
